MENU
+Compare
NBTX
Stock ticker: NASDAQ
AS OF
Jul 24 closing price
Price
$6.50
Change
+$0.70 (+12.07%)
Capitalization
276M

NBTX Nanobiotix SA Forecast, Technical & Fundamental Analysis

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy... Show more

NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NBTX with price predictions
Jul 24, 2025

NBTX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for NBTX turned positive on July 23, 2025. Looking at past instances where NBTX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 23, 2025. You may want to consider a long position or call options on NBTX as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 50-day moving average for NBTX moved above the 200-day moving average on June 24, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where NBTX advanced for three days, in of 184 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 82 cases where NBTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 45 cases where NBTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NBTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NBTX broke above its upper Bollinger Band on July 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NBTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.664). P/E Ratio (0.000) is within average values for comparable stocks, (59.851). NBTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.578). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (3.434) is also within normal values, averaging (279.346).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NBTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NBTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NBTX is expected to report earnings to fall 68.49% to -35 cents per share on September 04

Nanobiotix SA NBTX Stock Earnings Reports
Q2'25
Est.
$-0.35
Q4'24
Missed
by $0.39
Q2'24
Est.
$-0.51
Q4'23
Beat
by $0.75
The last earnings report on April 02 showed earnings per share of -112 cents, missing the estimate of -73 cents. With 36.35K shares outstanding, the current market capitalization sits at 276.00M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
60 Rue de Wattignies
Phone
+33 140260470
Employees
102
Web
https://www.nanobiotix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BECTY9.30N/A
N/A
Bechtle AG
LEAT10.00N/A
N/A
Leatt Corp.
PINXY12.80N/A
N/A
Peoples Insurance Company Group China
SIGY2.80N/A
N/A
Sigyn Therapeutics Inc.
JTGPF1.90N/A
N/A
JUST GROUP PLC

NBTX and Stocks

Correlation & Price change

A.I.dvisor tells us that NBTX and PBYI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and PBYI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBTX
1D Price
Change %
NBTX100%
+13.95%
PBYI - NBTX
28%
Poorly correlated
-0.58%
GLMD - NBTX
26%
Poorly correlated
+5.65%
HUMA - NBTX
26%
Poorly correlated
+18.70%
NVO - NBTX
26%
Poorly correlated
+4.87%
CRMD - NBTX
25%
Poorly correlated
+5.06%
More